Clinical use of tranexamic acid: evidences and controversies
Braz. J. Anesth. (Impr.); 72 (6), 2022
Abstract Tranexamic acid (TXA) significantly reduces blood loss in a wide range of surgical procedures and improves survival rates in obstetric and trauma patients with severe bleeding. Although it mainly acts as a fibrinolysis inhibitor, it also has an anti-inflammatory effect, and may help attenuate th...